New AI-based screening strategy uses ECG to detect heart defects

Researchers explore the use of artificial intelligence in enhancing the yield of conventional screening for ASDs using 12-lead electrocardiography.

FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT WITH NEOLUMINA BIOSCIENCE INC. – Psychedelic Alpha

NeoLumina’s license for Filament’s botanical psilocybin drug candidate provides exclusive global right to clinical and commercial development for eating disorders VANCOUVER, BC, June 30, 2023

June 30, 2023

FTC investigates Teva over contested product patents – Pharmaceutical Technology

Patents for AirDuo Respiclick, AirDuo Digihaler, ArmonAir Respiclick, and ArmonAir Digihaler products are being investigated. Credits: JHVEPhoto/Shutterstock.com Months after sending warning letters to pharma manufacturers

July 2, 2024

RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC

A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at preventing little children from being hospitalized with RSV, according to

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.